PHGE
BiomXยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PHGE Profile
Biomx Inc.
A clinical-stage microbiome company that develops therapies to target and destroy harmful bacteria in chronic diseases
22 Einstein St., Floor 4, Ness Ziona, Israel 7414003
--
BiomX Inc. was incorporated under the laws of the State of Delaware on November 1, 2017. On October 28, 2019, the company merged with BiomX Ltd., then changed its name to BiomX Inc. The company is developing natural and engineered phage mixtures designed to target and eliminate harmful bacteria in chronic diseases, and is currently focusing on cystic fibrosis and, to a lesser extent, atopic dermatitis. The company discovers and validates proprietary bacterial targets and customizes phage compositions for these targets.
